Honigman LLP announced that it is expanding its Washington D.C. office with the addition of N. Danny Shulman as partner. Shulman, who will be part of...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised Green Brick, and Latham advised the underwriter on the offering. Green Brick Partners, Inc. (NYSE: GRBK) announced the pricing of a secondary offering...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
You must be a Standard 1 Year member to access this content.
Morrison Foerster advised Unity Software Inc. on the deal, while Latham & Watkins advised ironSource. Unity Software Inc. (NYSE: U), the world’s leading platform for creating...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering. Stem, Inc. executed its US$400 million aggregate principal amount of 0.50% Green Convertible Senior Notes due 2028 in...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Pyxis Oncology, Inc., a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, working closely to Arthur Cox, represented Dole in the offering, while Latham & Watkins represented the underwriters. Dole plc, a newly...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Sight Sciences, Inc. in the offering, while Davis Polk advised the representatives of the several underwriters. Sight Sciences, Inc. executed its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alpha Tau in the transaction, while Winston & Strawn represented the placement agent. Alpha Tau Medical Limited, the developer of the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction. SQZ Biotechnologies Company (NYSE: SQZ) (SQZ), a cell therapy company developing novel treatments for multiple...
You must be a Standard 1 Year member to access this content.
